Imperial College London


Faculty of MedicineDepartment of Brain Sciences

Professor of Practice (Neurology)







12L12CLab BlockCharing Cross Campus





I work as part of the MS research team carrying out commercial and academic studies.  I am also involved in the biology of MS and novel imaging techniques.    



Cortese R, Carrasco FP, Tur C, et al., 2023, Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging, Neurology, Vol:100, ISSN:0028-3878, Pages:E308-E323

Forsberg L, Spelman T, Klyve P, et al., 2023, Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers., Mult Scler J Exp Transl Clin, Vol:9, ISSN:2055-2173

Montgomery SM, Green L, Karoui H, et al., 2023, To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting multiple sclerosis., J Med Econ, Vol:26, Pages:139-148

Barritt AW, Das E, Morley N, et al., 2022, Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, ISSN:1352-4585

Simpson-Yap S, Pirmani A, Kalincik T, et al., 2022, Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity, Neurology-neuroimmunology & Neuroinflammation, Vol:9, ISSN:2332-7812

More Publications